Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 13, 2001

View Archived Issues

First nonpeptide somatotropin sst3 antagonists reported

Genzyme acquires Novazyme Pharmaceuticals

Enrollment completed in second phase III trial of ranolazine for chronic angina

Phase I results reported for Merck KGaA's anti-EGF receptor MAb

Patient enrollment for phase I study of RIGScan CR set to begin

Colon cancer proteomics discovery partnership signed by Genomics Collaborative and ActivX

EMEA awards orphan product status to Surfaxin for MAS

Desloratadine approved in the E.U. for symptoms of chronic idiopathic urticaria

Strategy for systemic administration of Reolysin explored

Merck & Co. reports novel farnesyltransferase inhibitor with excellent cell potency

Compounds useful as cell adhesion inhibitors patented by Aventis and Genentech

Taisho identifies PGD2-like agonists potentially useful for cardiovascular disorders

PG derivatives for prevention and treatment of vascular hypertrophy described by Taisho

NK1 antagonists useful for treating asthma and allergic rhinitis reported by UCB

COR Therapeutics reports new selective factor Xa inhibitors

Quadruple therapy including both nelfinavir and efavirenz improves response in HIV patients

Copaxone approved by 15 European countries for the treatment of MS

Transtec receives marketing approval in Germany for the treatment of nonacute pain

FDA advisory committee recommends approval of Tracleer for PAH

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...